U.S. Silent to GlaxoSmithKline About Oil-for-Food Probe

The drug maker has also fallen under the gaze of a separate, industry-wide probe into potential FCPA violations in the pharmaceutical industry currently being conducted by the SEC and the Justice Department.

Unlock unlimited access to all Global Investigations Review content